Erythroid progenitors from patients with low-risk myelodysplastic syndromes are dependent on the surrounding micro environment for their survival

被引:1
|
作者
Folkerts, Hendrik [1 ]
Hazenberg, Carin L. E. [1 ]
Houwerzijl, Ewout J. [2 ]
van den Heuvel, Fiona A. J. [1 ,3 ]
Mulder, Andre B. [3 ]
van der Want, Johannes J. L. [4 ,5 ]
Vellenga, Edo [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9700 RB Groningen, Netherlands
[5] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
关键词
BONE-MARROW; ENHANCED AUTOPHAGY; STEM-CELL; MEGAKARYOCYTES; PRECURSORS; HEMATON;
D O I
10.1016/j.exphem.2014.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate whether the type of programmed cell death of myelodysplastic erythroid cells depends on their cellular context, we performed studies on cells from patients with low-risk myelodysplastic syndromes. We compared erythroid cells (and their precursor cells) from the mononuclear cell fraction with those from the hematon fraction, which are compacted complexes of hematopoietic cells surrounded by their own micro-environment. In directly fixed materials, erythroblasts exhibited signs of autophagy with limited apoptosis (<3%) based on ultrastructural characteristics and immunogold labeling for activated caspase-3. After 24 h in culture, myelodysplastic erythroblasts exhibited a significant increase in apoptosis (22 +/- 7% vs. 3 +/- 2%, p = 0.001). In contrast, the myelodysplastic erythroblasts from the hematon fraction did not exhibit an increased tendency toward apoptosis after culture (7 +/- 3.3% vs. 1.8 +/- 2.3%), which was in line with results for normal bone marrow cells. The same dependency on the micro-environment was noted for immature erythroid progenitor cells. Myelodysplastic hematons exhibited distinct numbers of erythroid burst-forming units in association with an extensive network of stromal cells, whereas small numbers of erythroid burst-forming units were generated from the myelodysplastic mononuclear cells compared with normal mononuclear cells (10.2 +/- 9 vs. 162 +/- 125, p < 0.001). Co-culture of erythroid myelodysplastic cells in the presence of growth factors (vascular endothelial growth factor, leukemia inhibitory factor) or on the MS-5 stromal layer did not restore the expansion of erythroid precursor cells. These data indicate that surviving myelodysplastic erythroid progenitors become more vulnerable to programmed cell death when they are detached from their own micro-environment. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 50 条
  • [21] Is Luspatercept the New Standard of Care in Transfusion- Dependent Low-Risk Myelodysplastic Syndromes?
    Garcia-Manero, Guillermo
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (08) : 367 - 369
  • [22] High-dose rHuEPO for the treatment of patients with low-risk myelodysplastic syndromes
    Latagliata, R.
    Oliva, E.
    Volpicelli, P.
    Napoleone, L.
    Carmosino, I.
    Breccia, M.
    Stefanizzi, C.
    Vincelli, I.
    Alati, C.
    Vozella, F.
    Nobile, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2009, 33 : S121 - S121
  • [23] CORRELATIONS OF TYPE OF RESPONSE TO EPO, WHO DIAGNOSIS AND SERUM EPO WITH IMMUNOPHENOTYPE OF ERYTHROID PROGENITORS AND PRECURSORS OF PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROMES
    Raddi, M. G.
    Attardi, E.
    Consagra, A.
    Amato, C.
    Santini, V.
    Brogi, A.
    Masala, E.
    Peruzzi, B.
    Bencini, S.
    Caporale, R.
    Sanna, A.
    HAEMATOLOGICA, 2021, 106 (10) : 76 - 77
  • [24] Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
    Tehranchi, R
    Invernizzi, R
    Grandien, A
    Zhivotovsky, B
    Fadeel, B
    Forsblom, AM
    Travaglino, E
    Samuelsson, J
    Hast, R
    Nilsson, L
    Cazzola, M
    Wibom, R
    Hellström-Lindberg, E
    BLOOD, 2005, 106 (01) : 247 - 253
  • [25] Moving low-risk myelodysplastic syndromes from humans to mice: is it truly that simple?
    Coriu, Daniel
    Stancioaica, Maria -Camelia
    HAEMATOLOGICA, 2024, 109 (01) : 8 - 10
  • [26] Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes
    Gianelli, Umberto
    Fracchiolla, Nicola Stefano
    Cortelezzi, Agostino
    Pellegrini, Caterina
    Savi, Federica
    Moro, Alessia
    Grimoldi, Maria Grazia
    Deliliers, Giorgio Lambertenghi
    Coggi, Guido
    Bosari, Silvano
    ANNALS OF HEMATOLOGY, 2007, 86 (03) : 185 - 189
  • [27] Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes
    Umberto Gianelli
    Nicola Stefano Fracchiolla
    Agostino Cortelezzi
    Caterina Pellegrini
    Federica Savi
    Alessia Moro
    Maria Grazia Grimoldi
    Giorgio Lambertenghi Deliliers
    Guido Coggi
    Silvano Bosari
    Annals of Hematology, 2007, 86 : 185 - 189
  • [28] Treatment of low-risk myelodysplastic syndromes by erythroprotein and its derivatives
    Villeval, Jean-Luc
    Sainty, Danielle
    HEMATOLOGIE, 2006, 12 : 10 - 11
  • [29] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
    Angel F. Remacha
    Beatriz Arrizabalaga
    Consuelo Del Cañizo
    Guillermo Sanz
    Ana Villegas
    Annals of Hematology, 2010, 89 : 147 - 154
  • [30] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
    Remacha, Angel F.
    Arrizabalaga, Beatriz
    Del Canizo, Consuelo
    Sanz, Guillermo
    Villegas, Ana
    ANNALS OF HEMATOLOGY, 2010, 89 (02) : 147 - 154